IHH Healthcare, a Malaysian hospital group, is considering the potential sale of its China unit, in a deal that could value the chain at as much as US$1 billion, according to people familiar with the situation.
The Kuala Lumpur-based company is in discussions with potential advisers on a possible sale of Parkway China, the people said, asking not to be named as the information is private.
Taikang Insurance Group and Shanghai Hongxin Medical Investment Holding Co. are also weighing participating in the sale, the people said. Taikang is a minority shareholder in the Malaysian firm’s mainland China portfolio, while Shanghai Hongxin holds a stake in one of its hospitals, according to a statement.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
